IDPH Reports 5 Illinois Counties at an Elevated Community Level for COVID-19
ILLINOIS, February 3 - White House and Governor Pritzker Announce Emergency Declarations to Expire in May; IDPH Pledges to Remain Vigilant and Protect Those Most At-Risk
The updated data was released days after the White House and Governor JB Pritzker announced that emergency declarations related to COVID-19 will expire on May 11. IDPH has recorded a total of 4,029,905 cases and 36,167 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 10,137 new confirmed and probable cases of COVID-19 in Illinois in the week ending January 29, and 76 deaths.
"It is welcome news that the White House and Governor Pritzker have announced that we are in a position to wind down the COVID-19 public health emergencies. This will give IDPH and our partners time to plan for the transition," said IDPH Director Dr. Sameer Vohra. "However, we want the public to know that we will not let down our guard when it comes to protecting Illinoisans from COVID-19. The virus is still circulating and causing hospitalizations and deaths in the state. This is why we continue to focus our efforts on promoting vaccinations, testing and timely treatment, especially when it comes to protecting our most vulnerable friends and neighbors."
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
The CDC authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series can now receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.
As of last night, 883 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 121 patients were in the ICU and 41 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 86 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.